subject: DRUGBANK:DB14330


subject: DRUGBANK:DB14330

subject_name: Macadamia oil

object_name: diabetes mellitus

tested_intervention: unsure


subject: DRUGBANK:DB14330

object_name: obesity due to melanocortin 4 receptor deficiency


subject: DRUGBANK:DB14330

object_name: obesity


subject: DRUGBANK:DB14330

object_name: Obesity, CTCAE


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS

object_name: Increased reactive oxygen species production


subject: CHEBI:35218

subject_name: anthocyanin cation

object_name: gestational diabetes


subject: CHEBI:35218


subject: CHEBI:36121

subject_name: flavylium


subject: CHEBI:36121


subject: CHEBI:40585

subject_name: ALFADEX


subject: CHEBI:40585


subject: PUBCHEM.COMPOUND:146014907

object_name: lung cancer


subject: PUBCHEM.COMPOUND:146014907

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:146014907

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:146014907

object_name: ovarian cancer


subject: PUBCHEM.COMPOUND:146014907

object_name: ovarian neoplasm


subject: PUBCHEM.COMPOUND:146014907

object_name: ovarian carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594483


subject: CHEMBL.COMPOUND:CHEMBL4594483


subject: CHEMBL.COMPOUND:CHEMBL4594483


subject: CHEMBL.COMPOUND:CHEMBL4594483


subject: CHEMBL.COMPOUND:CHEMBL4594483


subject: CHEMBL.COMPOUND:CHEMBL4594483


subject: UMLS:C4329606

subject_name: CTAG1 Antibody


subject: UMLS:C4329606


subject: UMLS:C4329606


subject: UMLS:C4329606


subject: UMLS:C4329606


subject: UMLS:C4329606


subject: UniProtKB:P78358

subject_name: CTG1B_HUMAN Cancer/testis antigen 1 (sprot)


subject: UniProtKB:P78358


subject: UniProtKB:P78358


subject: UniProtKB:P78358


subject: UniProtKB:P78358


subject: UniProtKB:P78358


subject: GTOPDB:12889

subject_name: elranatamab

object_name: AL amyloidosis


subject: UNII:L0HR9A577V

subject_name: Elranatamab


subject: UMLS:C4687515


subject: CHEBI:156095

subject_name: Lumefantrine

object_name: Plasmodium falciparum malaria


subject: CHEBI:52763


subject: CHEBI:6121

subject_name: Ketamine

object_name: Agitation, CTCAE 3.0


subject: CHEBI:6121

object_name: Agitation, CTCAE 5.0


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: acute coronary syndrome

tested_intervention: yes


subject: MESH:D057127

subject_name: Single-Chain Antibodies

object_name: osteoarthritis


subject: UNII:I4965C6W4O

object_name: Advanced cancer


subject: MESH:C433370

subject_name: Traumeel S

object_name: Oral Complication


subject: MESH:C433370

object_name: Childhood Neuroblastoma


subject: MESH:C433370

object_name: neuroblastoma


subject: MESH:C433370

object_name: renal carcinoma


subject: MESH:C433370

object_name: kidney neoplasm


subject: MESH:C433370

object_name: kidney cancer


subject: MESH:C433370

object_name: leukemia


subject: MESH:C433370

object_name: childhood leukemia


subject: MESH:C433370

object_name: adult lymphoma


subject: MESH:C433370

object_name: lymphoma


subject: MESH:C433370

object_name: pediatric lymphoma


subject: MESH:C433370

object_name: malignant soft tissue neoplasm


subject: MESH:C433370

object_name: sarcoma


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: pyoderma gangrenosum


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Thyroid cancer metastatic


subject: UNII:28X28X9OKV

object_name: Metastatic Thyroid Gland Papillary Carcinoma


subject: UNII:28X28X9OKV

object_name: Stage IV Thyroid Gland Papillary Carcinoma AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage IV Thyroid Gland Follicular Carcinoma AJCC v7


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C4547969

subject_name: apatinib mesylate

object_name: adrenal cortex carcinoma


subject: UMLS:C4547969

object_name: adenoid cystic carcinoma


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: female infertility


subject: CHEBI:60802

subject_name: ropivacaine

object_name: liver disorder


subject: CHEBI:60802

object_name: Metastatic malignant neoplasm to liver


subject: CHEBI:60802

object_name: liver neoplasm


subject: UNII:4XE5NDT4K1

subject_name: sodium-iodide symporter

object_name: Recurrent Endometrial Cancer


subject: UNII:4XE5NDT4K1

object_name: Metastatic Endometrial Carcinoma


subject: UNII:4XE5NDT4K1

object_name: Adenocarcinoma endometrial recurrent


subject: UNII:4XE5NDT4K1

object_name: Recurrent Endometrial Serous Adenocarcinoma


subject: UNII:4XE5NDT4K1

object_name: Recurrent Endometrial Endometrioid Adenocarcinoma


subject: UNII:4XE5NDT4K1

object_name: Recurrent Endometrial Clear Cell Adenocarcinoma


subject: UNII:4XE5NDT4K1

object_name: Recurrent Endometrial Mixed Cell Adenocarcinoma


subject: UNII:4XE5NDT4K1

object_name: Recurrent Endometrial Undifferentiated Carcinoma


subject: UNII:4XE5NDT4K1

object_name: Stage IV Uterine Corpus Cancer


subject: UNII:4XE5NDT4K1

object_name: Recurrent Uterine Corpus Carcinosarcoma


subject: PR:000015171

subject_name: sodium/iodide cotransporter


subject: PR:000015171


subject: PR:000015171


subject: PR:000015171


subject: PR:000015171


subject: PR:000015171


subject: PR:000015171


subject: PR:000015171


subject: PR:000015171


subject: PR:000015171


subject: UMLS:C0142963


subject: UMLS:C0142963


subject: UMLS:C0142963


subject: UMLS:C0142963


subject: UMLS:C0142963


subject: UMLS:C0142963


subject: UMLS:C0142963


subject: UMLS:C0142963


subject: UMLS:C0142963


subject: UMLS:C0142963


subject: CHEBI:66919

subject_name: Ruxolitinib


subject: CHEBI:66919


subject: CHEBI:66919


subject: CHEBI:66919


subject: CHEBI:66919


subject: CHEBI:66919


subject: CHEBI:66919


subject: CHEBI:66919


subject: CHEBI:66919


subject: CHEBI:66919


subject: CHEBI:33353

subject_name: technetium atom


subject: CHEBI:33353


subject: CHEBI:33353


subject: CHEBI:33353


subject: CHEBI:33353


subject: CHEBI:33353


subject: CHEBI:33353


subject: CHEBI:33353


subject: CHEBI:33353


subject: CHEBI:33353


subject: UMLS:C5667030

subject_name: Icovamenib

object_name: non-small cell lung carcinoma


subject: UMLS:C5667030

object_name: pancreatic neoplasm


subject: UMLS:C5667030

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5667030

object_name: malignant pancreatic neoplasm


subject: UMLS:C5667030

object_name: Matthew-Wood syndrome


subject: UMLS:C5667030

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C5667030

object_name: colorectal cancer


subject: UMLS:C5667030

object_name: colorectal carcinoma


subject: UMLS:C5667030

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5667030

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C5667030

object_name: Non-small cell lung cancer stage III


subject: UMLS:C5667030

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C5667030

object_name: stage IV pancreatic cancer


subject: UMLS:C5667030

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UMLS:C5667030

object_name: Stage IV Colorectal Cancer AJCC v7


subject: UMLS:C5667030

object_name: Stage IV Colorectal Cancer AJCC v6


subject: UMLS:C5667030

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UMLS:C5667030

object_name: Pancreatic carcinoma stage III


subject: UMLS:C5667030

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C5667030

object_name: Stage III Colorectal Cancer AJCC v6


subject: UMLS:C5667030

object_name: Stage III Colorectal Cancer AJCC v7


subject: UMLS:C5667030

object_name: KRAS mutation-related tumors


subject: UMLS:C5667030

object_name: Recurrent Carcinoma


subject: UMLS:C5667030

object_name: refractory malignant neoplasm


subject: UNII:I5I8VB78VT

subject_name: Erenumab

object_name: Episodic migraine


subject: CHEBI:24996

subject_name: lactate

object_name: Acute Stroke


subject: CHEBI:42111

subject_name: D-Lactic acid


subject: CHEBI:16411

subject_name: Indoleacetic acid


subject: MESH:D007773

subject_name: Lactates


subject: CHEBI:78320

subject_name: Lactic acid


subject: UMLS:C5226733

object_name: Allergy


subject: UMLS:C5226733

object_name: History of allergies


subject: UMLS:C0360094

subject_name: iv lidocaine

object_name: Intubation complication


subject: CHEBI:74705

subject_name: Met-Leu


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UMLS:C4053607

object_name: Parkinson disease


subject: CHEBI:4806

subject_name: Epigallocatechin gallate

object_name: Huntington disease


subject: CHEBI:8772

subject_name: Raloxifene

object_name: Androgen excess


subject: UMLS:C3642287

subject_name: Depo-Eligard

object_name: prostate carcinoma


subject: UMLS:C3642287

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: nephrolithiasis, calcium oxalate


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Positive Lymph Node


subject: UNII:DPT0O3T46P

object_name: Extrapulmonary Small Cell Carcinoma


subject: UMLS:C5433469

subject_name: Rejuveinix


subject: UMLS:C5433469

object_name: acute respiratory distress syndrome


subject: UMLS:C5433469

object_name: adult acute respiratory distress syndrome


subject: UMLS:C5433469

object_name: Hypoxemia


subject: UMLS:C5433469

object_name: Blood oxygen concentration below reference range (finding)


subject: MESH:C015418

subject_name: paraffin oils

object_name: Hirschsprung disease


subject: MESH:C015418

object_name: Hirschsprung disease, susceptibility to, 1


subject: PUBCHEM.COMPOUND:139291139

subject_name: Mineral oil


subject: PUBCHEM.COMPOUND:139291139


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: pediatric intraocular retinoblastoma


subject: UNII:PVI5M0M1GW

object_name: intraocular retinoblastoma


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: CHEBI:80165

object_name: sarcopenia


subject: CHEBI:80270


subject: PUBCHEM.COMPOUND:52943177


subject: PR:000008039

subject_name: GATA-type zinc finger protein 1


subject: UMLS:C0061355

subject_name: Glucagon-Like Peptide 1


subject: UMLS:C0101395

subject_name: Actrapid insulin


subject: UNII:7FY24HE2G3

subject_name: Tanakan

object_name: HIV infection


subject: GTOPDB:12989

subject_name: toripalimab

object_name: Esophageal Squamous Cell Carcinoma by AJCC v8 Stage


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: GTOPDB:7692

subject_name: pidilizumab

object_name: Stage IV Diffuse Large B-Cell Lymphoma


subject: GTOPDB:7692

object_name: Stage III Diffuse Large B-Cell Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL2108680

subject_name: PIDILIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL2108680


subject: UMLS:C2346821


subject: UMLS:C2346821


subject: CHEBI:45783

subject_name: Imatinib

object_name: small cell lung carcinoma


subject: CHEBI:140621

subject_name: Cisatracurium

object_name: familial acute respiratory distress syndrome, ANLN-related, dog


subject: CHEBI:140621

object_name: COVID-19-Associated Acute Respiratory Distress Syndrome


subject: CHEBI:2948

subject_name: Azathioprine

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:2948

object_name: Refractory acute myeloid leukemia


subject: GTOPDB:9592

subject_name: tislelizumab


subject: GTOPDB:9592


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: CHEBI:82339

subject_name: Merphalan

object_name: Miller-Dieker lissencephaly syndrome


subject: CHEBI:82339

object_name: myoclonic dystonia 11


subject: CHEBI:82339

object_name: leukemia, acute lymphocytic, susceptibility to, 1


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: Blood stem cell transplant failure


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: UMLS:C5239440

object_name: Hodgkin Disease


subject: UMLS:C5239440

object_name: Adult Hodgkin Lymphoma


subject: UMLS:C5239440

object_name: Childhood Hodgkin Lymphoma


subject: UMLS:C5239440

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5239440

object_name: acute myeloid leukemia


subject: UMLS:C5239440

object_name: chronic myelomonocytic leukemia


subject: UMLS:C5239440

object_name: juvenile myelomonocytic leukemia


subject: UMLS:C5239440

object_name: myeloproliferative neoplasm


subject: UMLS:C5239440

object_name: bone marrow neoplasm


subject: UMLS:C5239440

object_name: acute lymphoblastic leukemia


subject: UMLS:C5239440

object_name: Myelodysplasia


subject: UMLS:C5239440

object_name: non-Hodgkin lymphoma


subject: UMLS:C5239440


subject: UMLS:C5239440


subject: UMLS:C5239440


subject: UMLS:C5239440


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168


subject: UMLS:C5139677

object_name: colorectal neoplasm


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Recurrent WHO Grade 3 Glioma


subject: CHEBI:231614

object_name: grade III glioma


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: bone cancer


subject: UMLS:C4329339

object_name: Childhood Solid Neoplasm


subject: UMLS:C4329339

object_name: Adult Solid Neoplasm


subject: CHEBI:31539

subject_name: Epalrestat

object_name: PMM2-congenital disorder of glycosylation


subject: CHEBI:31539

object_name: congenital disorder of glycosylation type I


subject: UMLS:C5706286

subject_name: Jing Si Herbal Tea

object_name: bronchiectasis


subject: CHEBI:39462

subject_name: pilocarpine

object_name: Incontinence


subject: CHEBI:8207

subject_name: Pilocarpine


subject: CHEBI:9622

subject_name: Tolterodine


subject: CHEBI:63631

subject_name: Topiramate

object_name: cocaine abuse


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Advanced Esophageal Squamous Cell Carcinoma


subject: UNII:PQX0D8J21J

object_name: Advanced Head and Neck Squamous Cell Carcinoma


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: CHEBI:4672

subject_name: Docetaxel

object_name: cervical squamous cell carcinoma


subject: CHEBI:4672


subject: UMLS:C5854395

subject_name: HMBD 001


subject: UMLS:C5854395


subject: UMLS:C5854395


subject: CHEBI:184662

object_name: long COVID-19


subject: CHEBI:63608

subject_name: Maraviroc


subject: PUBCHEM.COMPOUND:64987


subject: CHEBI:63717

subject_name: Tenofovir disoproxil


subject: CHEBI:63625

subject_name: Tenofovir


subject: CHEBI:31536

subject_name: Emtricitabine


subject: CHEBI:28177

subject_name: Theophylline

object_name: acute myeloid leukemia


subject: CHEBI:63605

subject_name: Ixabepilone

object_name: leiomyosarcoma of the corpus uteri


subject: CHEBI:63605

object_name: Recurrent Uterine Corpus Sarcoma


subject: UMLS:C5854568

subject_name: Oncolytic HSV-1 R130

object_name: ear cancer


subject: UMLS:C5854568

object_name: Nose Neoplasms


subject: UMLS:C5854568

object_name: laryngeal carcinoma


subject: UMLS:C5854568

object_name: larynx cancer


subject: UMLS:C5854568

object_name: carcinoma of esophagus


subject: UMLS:C5854568

object_name: esophageal cancer


subject: UMLS:C5854568

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C5854568

object_name: neoplasm of esophagus


subject: UMLS:C5854568

object_name: pharynx cancer


subject: UMLS:C5854568

object_name: carcinoma of pharynx


subject: UMLS:C5854568

object_name: Otorhinolaryngologic Neoplasms


subject: UMLS:C0949110

subject_name: Aluminum hydroxide oral suspension BP

object_name: HIV-1 infection


subject: CHEBI:157844

subject_name: Glu-Arg

object_name: Childhood Breast Carcinoma


subject: CHEBI:157844

object_name: breast carcinoma


subject: CHEBI:157844

object_name: breast cancer


subject: CHEBI:33379

subject_name: erbium


subject: CHEBI:33379


subject: CHEBI:33379


subject: UMLS:C5441529

subject_name: Estrogen Receptor Family, human


subject: UMLS:C5441529


subject: UMLS:C5441529


subject: PR:000007204

subject_name: estrogen receptor


subject: PR:000007204


subject: PR:000007204


subject: UMLS:C1330419

subject_name: Niacin ER

object_name: hyperlipidemia


subject: UMLS:C1330419

object_name: hyperlipoproteinemia


subject: UMLS:C1330419

object_name: Hyperlipidemia, CTCAE


subject: UMLS:C1330419

object_name: Serum lipids high (finding)


subject: UMLS:C4724988

subject_name: Lm-tLLO-neoantigens Vaccine ADXS-NEO

object_name: metastatic melanoma


subject: UMLS:C4724988

object_name: Malignant neoplasm of colon stage IV


subject: UMLS:C4724988

object_name: Head and neck cancer metastatic


subject: UMLS:C4724988

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C4724988

object_name: urothelial carcinoma


subject: UMLS:C4724988

object_name: transitional cell carcinoma


subject: CHEBI:71219

subject_name: Pazopanib

object_name: Recurrent Primary Peritoneal Carcinoma


subject: CHEBI:71219

object_name: Recurrent ovarian cancer


subject: CHEBI:71219

object_name: Recurrent Fallopian Tube Carcinoma


subject: PUBCHEM.COMPOUND:138566969

subject_name: Baloxavir marboxil

object_name: Cross Infection


subject: PUBCHEM.COMPOUND:544190


subject: CHEBI:7798

subject_name: Oseltamivir


subject: CHEBI:6931

subject_name: Midazolam

object_name: cataract


subject: CHEBI:6931

object_name: Cataract, CTCAE 3.0


subject: CHEBI:6931

object_name: Cataract, CTCAE 5.0


subject: CHEBI:6931

object_name: cataract on exam (physical finding)


subject: CHEBI:74705

subject_name: Met-Leu


subject: CHEBI:74705


subject: CHEBI:74705


subject: CHEBI:74705


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: CHEBI:6775

subject_name: Mesalazine

object_name: eosinophilic esophagitis


subject: CHEBI:6775

object_name: Eosinophilic infiltration of the esophagus


subject: UMLS:C5418074

subject_name: ADC MRG002

object_name: non-small cell lung carcinoma


subject: UNII:YET2XNU791

object_name: cancer


subject: UNII:YET2XNU791

object_name: neoplasm


subject: UNII:A49A7A5YN4

subject_name: Alflutinib

object_name: CNS metastases


subject: UNII:A49A7A5YN4

object_name: neoplastic meningitis


subject: UNII:A49A7A5YN4

object_name: Epidermal growth factor receptor positive non-small cell lung cancer


subject: UNII:513P80B4YJ

subject_name: Avapritinib

object_name: KIT mutation-related tumors


subject: PUBCHEM.COMPOUND:9995208

subject_name: Estetrol

object_name: vasomotor symptom


subject: PUBCHEM.COMPOUND:9995208

object_name: Menopausal Symptom


subject: CHEBI:17026

subject_name: Progesterone


subject: CHEBI:17026


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: UMLS:C2757070


subject: CHEBI:135005

subject_name: Milnacipran

object_name: sleep disorder


subject: CHEBI:78825

subject_name: Avutometinib

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:78825

object_name: Embolism, Tumor


subject: CHEBI:78825

object_name: Neoplasm Metastasis


subject: CHEBI:78825

object_name: pancreatic neoplasm


subject: CHEBI:78825

object_name: exocrine pancreatic carcinoma


subject: CHEBI:78825

object_name: malignant pancreatic neoplasm


subject: UMLS:C2703210


subject: UMLS:C2703210


subject: UMLS:C2703210


subject: UMLS:C2703210


subject: UMLS:C2703210


subject: UMLS:C2703210


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: KRAS Activating Mutation


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: CHEBI:45863

subject_name: Paclitaxel


subject: GTOPDB:8944

subject_name: emactuzumab


subject: GTOPDB:8944


subject: UNII:6FY6EI1X8R


subject: UNII:6FY6EI1X8R


subject: UMLS:C4078926


subject: UMLS:C4078926


subject: CHEBI:8093

subject_name: Phenylephrine

object_name: Heart Disease Risk Factors


subject: CHEBI:180664

subject_name: Tempol

object_name: Pathologic vasoconstriction


subject: CHEBI:180664

object_name: Vasoconstriction


subject: CHEBI:180664

object_name: cardiovascular disorder


subject: CHEBI:180664


subject: UNII:3HP012Q0FH

object_name: Branch retinal vein occlusion


subject: UNII:2H1PA8H1EN

subject_name: Pegaptanib


subject: UMLS:C1567931

subject_name: Macugen


subject: CHEBI:64312

subject_name: Memantine

object_name: alcohol abuse


subject: CHEBI:70839

subject_name: Dasatinib

object_name: squamous cell lung carcinoma


subject: CHEBI:190514


subject: CHEBI:49375


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab

object_name: Myelodysplasia


subject: UNII:QEN1X95CIX

object_name: Adult Myelodysplastic Syndrome


subject: UNII:QEN1X95CIX

object_name: childhood myelodysplastic syndrome


subject: UNII:QEN1X95CIX

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: CHEBI:8707

subject_name: Quetiapine

object_name: chronic kidney disease


subject: CHEBI:5147

subject_name: Formoterol

object_name: Physiologic hypertrophy


subject: CHEBI:5147

object_name: hypertrophy


subject: CHEBI:408174

subject_name: Arformoterol


subject: CHEBI:408174


subject: CHEBI:9449

subject_name: Terbutaline


subject: CHEBI:9449


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Hallux valgus


subject: UMLS:C0962969

subject_name: RAD 001

object_name: neurofibromatosis


subject: UMLS:C0962969

object_name: acoustic neuroma


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:108169

subject_name: Taxane

object_name: cervical cancer


subject: PUBCHEM.COMPOUND:108169

object_name: cervical carcinoma


subject: UMLS:C0796419

subject_name: Taxanes


subject: UMLS:C0796419


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: conduct disorder


subject: UNII:6ST3ZF52WB

subject_name: Carboxyamidotriazole

object_name: renal carcinoma


subject: UNII:6ST3ZF52WB

object_name: kidney neoplasm


subject: UNII:6ST3ZF52WB

object_name: kidney cancer


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: neurogenic arthropathy


subject: UNII:6XC1PAD3KF

object_name: Complications of Diabetes Mellitus


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: Femur fracture


subject: CHEBI:5931

subject_name: insulin human

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:5931

object_name: Myocardial Infarction by ECG Finding


subject: UMLS:C0876064

subject_name: Lantus


subject: UMLS:C0876064


subject: UMLS:C0876064

object_name: cardiovascular disorder


subject: UNII:39IS23Q1EW

subject_name: Cedazuridine

object_name: Clonal Cytopenia of Undetermined Significance


subject: UNII:39IS23Q1EW

object_name: Cytopenia


subject: CHEBI:66964

subject_name: Dronabinol

object_name: Alcoholic Intoxication


subject: CHEBI:28645

subject_name: FRUCTOSE

object_name: visceral steatosis, congenital


subject: CHEBI:48095

subject_name: keto-D-fructose


subject: CHEBI:17925

subject_name: alpha-D-glucose


subject: PUBCHEM.COMPOUND:24749

subject_name: Polyglucose


subject: CHEBI:17234

subject_name: D-glucose


subject: GTOPDB:9195

subject_name: clazakizumab

object_name: Inflammation


subject: GTOPDB:9195

object_name: Frailty


subject: UNII:4S38Z8RA9O


subject: UNII:4S38Z8RA9O


subject: UMLS:C2830049


subject: UMLS:C2830049


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Pain, Procedural


subject: CHEBI:55438

subject_name: Angiotensin 1-7

object_name: Myelodysplasia


subject: UMLS:C0103306


subject: UNII:4B93MGE4AL

subject_name: Futibatinib

object_name: Metastatic hepatocellular carcinoma


subject: UNII:4B93MGE4AL

object_name: BCLC Stage A Hepatocellular Carcinoma


subject: UNII:4B93MGE4AL

object_name: Advanced Hepatocellular Carcinoma


subject: UNII:4B93MGE4AL

object_name: BCLC Stage C Hepatocellular Carcinoma


subject: UNII:4B93MGE4AL

object_name: BCLC Stage B Hepatocellular Carcinoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:67988

subject_name: Ginsenoside Rd

object_name: Ischemic stroke


subject: PUBCHEM.COMPOUND:12855925

subject_name: Ginsenoside-Rd


subject: CHEBI:15698

subject_name: Deoxycytidine

object_name: head and neck squamous cell carcinoma


subject: CHEBI:16991

subject_name: DNA


subject: CHEBI:9139

subject_name: Sildenafil

object_name: Fetal distress


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: Extrapulmonary Small Cell Carcinoma


subject: CHEBI:233362

object_name: pulmonary large cell neuroendocrine carcinoma


subject: CHEBI:4031

subject_name: Cyclosporine

object_name: autoimmune thrombocytopenia


subject: CHEBI:4031

object_name: thrombocytopenia due to immune destruction


subject: CHEBI:190738

subject_name: Demethylated antipyrine

object_name: myocardial infarction


subject: CHEBI:190738

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:190738

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:190738

object_name: Reperfusion Injury


subject: UNII:S798V6YJRP

subject_name: EDARAVONE


subject: UNII:S798V6YJRP


subject: UNII:S798V6YJRP


subject: UNII:S798V6YJRP


subject: CHEBI:31530

subject_name: Edaravone


subject: CHEBI:31530


subject: CHEBI:31530


subject: CHEBI:31530


subject: UNII:4D6Q6HGC7Z

subject_name: Lesogaberan

object_name: Regurgitates after swallowing


subject: UNII:4D6Q6HGC7Z

object_name: Regurgitation


subject: DRUGBANK:DB05404


subject: DRUGBANK:DB05404


subject: GTOPDB:10197

subject_name: vantictumab

object_name: pancreatic neoplasm


subject: GTOPDB:10197

object_name: exocrine pancreatic carcinoma


subject: GTOPDB:10197

object_name: malignant pancreatic neoplasm


subject: GTOPDB:10197

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: GTOPDB:10197

object_name: stage IV pancreatic cancer


subject: GTOPDB:10197

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UNII:88WBI2D80S

subject_name: VANTICTUMAB


subject: UNII:88WBI2D80S


subject: UNII:88WBI2D80S


subject: UNII:88WBI2D80S


subject: UNII:88WBI2D80S


subject: UNII:88WBI2D80S


subject: UMLS:C3273041

subject_name: Vantictumab


subject: UMLS:C3273041


subject: UMLS:C3273041


subject: UMLS:C3273041


subject: UMLS:C3273041


subject: UMLS:C3273041


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: HIV infection


subject: CHEBI:9907

subject_name: ursodiol

object_name: polycystic liver disease 1


subject: CHEBI:9907

object_name: autosomal dominant polycystic liver disease


subject: CHEBI:9907

object_name: autosomal dominant polycystic kidney disease


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: malignant epithelial tumor of ovary


subject: UNII:5S371K6132

object_name: Bone Mineral Density


subject: UMLS:C4547969

subject_name: apatinib mesylate

object_name: ovarian carcinoma


subject: UMLS:C4547969


subject: UMLS:C4547969


subject: UNII:TWF0ML1CK8

subject_name: Fluzoparib


subject: UNII:TWF0ML1CK8


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: Neck pain


subject: PUBCHEM.COMPOUND:6096882

object_name: Neck Pain, CTCAE 5.0


subject: PUBCHEM.COMPOUND:6096882

object_name: Neck Pain, CTCAE 3.0


subject: PUBCHEM.COMPOUND:6096882

object_name: Back Pain, CTCAE 5.0


subject: PUBCHEM.COMPOUND:6096882

object_name: Back pain


subject: PUBCHEM.COMPOUND:6096882

object_name: Back Pain, CTCAE 3.0


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UMLS:C0013343

subject_name: Dyes


subject: UMLS:C0013343


subject: UMLS:C0013343


subject: UMLS:C0013343


subject: UMLS:C0013343


subject: UMLS:C0013343


subject: PR:000022123

subject_name: aerobic respiration control protein ArcA


subject: PR:000022123


subject: PR:000022123


subject: PR:000022123


subject: PR:000022123


subject: PR:000022123


subject: UniProtKB:P0A9Q1

subject_name: ARCA_ECOLI Aerobic respiration control protein ArcA (sprot)


subject: UniProtKB:P0A9Q1


subject: UniProtKB:P0A9Q1


subject: UniProtKB:P0A9Q1


subject: UniProtKB:P0A9Q1


subject: UniProtKB:P0A9Q1


subject: CHEMBL.COMPOUND:CHEMBL5095484

subject_name: REMTERNETUG

object_name: familial Alzheimer disease


subject: CHEMBL.COMPOUND:CHEMBL5095484

object_name: Presenile dementia


subject: CHEMBL.COMPOUND:CHEMBL5095484

object_name: dementia


subject: UMLS:C5783906

subject_name: Remternetug


subject: UMLS:C5783906


subject: UMLS:C5783906


subject: UNII:UPC6BTX7PY

subject_name: INCLISIRAN SODIUM

object_name: Heart Disease Risk Factors


subject: GTOPDB:13624

subject_name: inclisiran


subject: UNII:R67KC9COEN

object_name: Chronic obstructive pulmonary disease of horses


subject: UNII:R67KC9COEN

object_name: COPD, severe early onset


subject: UNII:R67KC9COEN

object_name: chronic obstructive pulmonary disease


subject: CHEMBL.COMPOUND:CHEMBL3707249


subject: CHEMBL.COMPOUND:CHEMBL3707249


subject: CHEMBL.COMPOUND:CHEMBL3707249


subject: UMLS:C2826380

subject_name: Irinotecan-Eluting Beads

object_name: stage IVA rectal cancer


subject: UMLS:C2826380

object_name: Stage IVA Rectal Cancer AJCC v7


subject: UMLS:C2826380

object_name: Stage IVA Rectal Cancer AJCC v8


subject: UMLS:C2826380

object_name: Stage IVB Rectal Cancer AJCC v7


subject: UMLS:C2826380

object_name: Stage IVB Rectal Cancer AJCC v8


subject: UMLS:C2826380

object_name: stage IVB rectal cancer


subject: UMLS:C2826380

object_name: stage IVB colon cancer


subject: UMLS:C2826380

object_name: Stage IVB Colon Cancer AJCC v7


subject: UMLS:C2826380

object_name: Stage IVB Colon Cancer AJCC v8


subject: UMLS:C2826380

object_name: stage IVA colon cancer


subject: UMLS:C2826380

object_name: Stage IVA Colon Cancer AJCC v7


subject: UMLS:C2826380

object_name: Stage IVA Colon Cancer AJCC v8


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: Uses contraception (finding)


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UNII:YX55DXP4T1

object_name: asthma


subject: CHEBI:31159

subject_name: Aceclofenac

object_name: rheumatoid arthritis


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: post operative nausea and vomiting


subject: CHEBI:46195

object_name: Oculocardiac Reflex


subject: CHEBI:63660

object_name: schizophrenia 18


subject: CHEBI:63618

subject_name: Pravastatin


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: ovarian cancer


subject: CHEBI:25681

object_name: ovarian neoplasm


subject: UMLS:C3536908

subject_name: Omega-3 Fatty Acid [EPC]


subject: UMLS:C3536908


subject: CHEBI:44915

subject_name: Propofol

object_name: Pruritus vulvae


subject: CHEBI:36704

subject_name: Imiquimod

object_name: superficial multifocal basal cell carcinoma


subject: CHEBI:71219

subject_name: Pazopanib

object_name: Alveolar soft part sarcoma metastatic


subject: UNII:LPU25F15UQ

subject_name: Azeliragon

object_name: glioblastoma


subject: UNII:LPU25F15UQ

object_name: Childhood Glioblastoma


subject: UNII:LPU25F15UQ

object_name: adult glioblastoma


subject: UNII:T2DAA4TB22

subject_name: MEDA

object_name: extranodal nasal NK/T cell lymphoma


subject: UMLS:C5235404

subject_name: Aurora a kinase inhibitor ly3295668

object_name: small cell lung carcinoma


subject: UMLS:C5235404

object_name: Adult Solid Neoplasm


subject: UMLS:C5235404

object_name: Neoplasm Metastasis


subject: UMLS:C5235404

object_name: breast neoplasm


subject: UMLS:C5235404

object_name: triple-negative breast carcinoma


subject: UMLS:C5235404

object_name: head and neck neoplasm


subject: UMLS:C5235404

object_name: neoplasm


subject: UMLS:C2986991

subject_name: VEGFR2-targeted Contrast Agent BR55

object_name: prostate carcinoma


subject: UMLS:C2986991

object_name: prostate cancer


subject: UNII:4988K7X26P

subject_name: Fosamax

object_name: Childhood Breast Carcinoma


subject: UNII:4988K7X26P

object_name: breast carcinoma


subject: UNII:4988K7X26P

object_name: breast cancer


subject: CHEBI:2567

subject_name: Alendronic acid


subject: CHEBI:2567


subject: CHEBI:2567


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: type 1 diabetes mellitus 1


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class


subject: UMLS:C3714803

object_name: type 1 diabetes mellitus


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: CHEBI:30879

subject_name: alcohol

object_name: Tremor


subject: CHEBI:30879

object_name: Tremor, CTCAE_5


subject: CHEBI:30879

object_name: Tremor, CTCAE_3


subject: CHEBI:16236

subject_name: Ethanol


subject: CHEBI:16236


subject: CHEBI:16236


subject: CHEBI:38290

object_name: end stage renal failure


subject: CHEBI:176783


subject: UMLS:C3714687


subject: UMLS:C2349136


subject: CHEBI:22652


subject: UMLS:C4522080


subject: CHEBI:57986

object_name: Unspecified complication of corneal transplant


subject: CHEBI:57986

object_name: ocular cicatricial pemphigoid


subject: CHEBI:57986

object_name: EXCESS LMW-DNA


subject: CHEBI:57986

object_name: Stevens-Johnson syndrome


subject: CHEBI:57986

object_name: rheumatoid arthritis


subject: CHEBI:57986

object_name: Autoimmunity


subject: CHEBI:57986

object_name: Chemical injury


subject: UMLS:C3714502

subject_name: Riboflavin Drug Class


subject: UMLS:C3714502


subject: UMLS:C3714502


subject: UMLS:C3714502


subject: UMLS:C3714502


subject: UMLS:C3714502


subject: UMLS:C3714502


subject: CHEBI:17621

subject_name: FMN


subject: CHEBI:17621


subject: CHEBI:17621


subject: CHEBI:17621


subject: CHEBI:17621


subject: CHEBI:17621


subject: CHEBI:17621


subject: CHEBI:17015

subject_name: Riboflavin


subject: CHEBI:17015


subject: CHEBI:17015


subject: CHEBI:17015


subject: CHEBI:17015


subject: CHEBI:17015


subject: CHEBI:17015


subject: HMDB:HMDB0255819

subject_name: Nusinersen


subject: HMDB:HMDB0255819


subject: HMDB:HMDB0255819


subject: HMDB:HMDB0255819

object_name: Involuntary movements


subject: HMDB:HMDB0255819

object_name: motor neuron disorder


subject: MESH:C000726227

object_name: Adverse drug response


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: Epistaxis, CTCAE


subject: CHEBI:60648

object_name: Epistaxis


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: CHEBI:60481

object_name: Osteopenia


subject: CHEBI:90926

subject_name: Tenofovir alafenamide


subject: PR:000008953

subject_name: insulin-like growth factor-binding protein 7


subject: CHEBI:2668

subject_name: Amlodipine

object_name: type 1 diabetes mellitus


subject: CHEBI:2668

object_name: diabetic retinopathy


subject: CHEBI:2668

object_name: Complications of Diabetes Mellitus


subject: CHEBI:2668

object_name: eye disorder


subject: CHEBI:6503

subject_name: LISINOPRIL


subject: CHEBI:6503


subject: CHEBI:6503


subject: CHEBI:43755

subject_name: Lisinopril


subject: CHEBI:43755


subject: CHEBI:43755


subject: UMLS:C1330353

subject_name: In-111 Zevalin

object_name: diffuse large B-cell lymphoma


subject: UMLS:C1330353

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UMLS:C1330353

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UMLS:C1330353

object_name: follicular lymphoma


subject: UMLS:C1135144

subject_name: Y90 Zevalin


subject: UMLS:C1135144


subject: UMLS:C1135144


subject: UMLS:C1135144


subject: UMLS:C1330608

subject_name: Y-90 Zevalin


subject: UMLS:C1330608


subject: UMLS:C1330608


subject: UMLS:C1330608


subject: UMLS:C0720492

subject_name: Fluzone

object_name: Gammopathy


subject: CHEBI:58097

object_name: Dyspnea


subject: CHEBI:58097

object_name: Dyspnea, CTCAE


subject: CHEBI:58097

object_name: cardiovascular surgery result: dyspnea


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Locally Advanced Adrenal Cortical Carcinoma


subject: CHEBI:72317

object_name: Metastatic Adrenal Cortical Carcinoma


subject: UNII:6QVL057INT

subject_name: Cemiplimab


subject: UNII:6QVL057INT


subject: UNII:6QVL057INT

object_name: Unresectable Adrenal Cortical Carcinoma


subject: UNII:6QVL057INT

object_name: Recurrent Adrenal Cortical Carcinoma


subject: UNII:6QVL057INT

object_name: Stage IV Adrenal Cortex Carcinoma AJCC v8


subject: UNII:6QVL057INT

object_name: Stage III Adrenal Cortex Carcinoma AJCC v8


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UNII:RZ22DI43TP

subject_name: PROTHROMBIN COMPLEX CONCENTRATE

object_name: blood coagulation disease


subject: UMLS:C0072434

subject_name: prothrombin complex concentrates


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Increased reactive oxygen species production


subject: CHEBI:7936

subject_name: Paroxetine

object_name: Premenstrual Dysphoric Disorder


subject: CHEBI:44915

subject_name: Propofol

object_name: pervasive developmental disorder


subject: CHEBI:44915

object_name: autism


subject: CHEBI:44915

object_name: autism spectrum disorder


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: acute graft versus host disease


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:84040

object_name: sarcopenia


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:27881

subject_name: resveratrol


subject: UMLS:C0728976

subject_name: Control brand of phenylpropanolamine

object_name: Ehlers-Danlos syndrome, vascular type


subject: UMLS:C0728976

object_name: autosomal dominant Ehlers-Danlos syndrome, vascular type


subject: UMLS:C0728976

object_name: chromosome 2q31.2 deletion syndrome


subject: UMLS:C0308718

subject_name: CONTROL veterinary product


subject: UMLS:C0308718


subject: UMLS:C0308718


subject: UMLS:C1550141

subject_name: control substance


subject: UMLS:C1550141


subject: UMLS:C1550141


subject: CHEBI:94461

subject_name: Celiprolol


subject: CHEBI:94461


subject: CHEBI:94461


subject: DRUGBANK:DB14101

subject_name: Soy isoflavones

object_name: migraine


subject: CHEMBL.COMPOUND:CHEMBL3989979

subject_name: RIVOGENLECLEUCEL

object_name: acute myeloid leukemia by FAB classification


subject: CHEMBL.COMPOUND:CHEMBL3989979

object_name: acute myeloid leukemia


subject: UMLS:C0499161

subject_name: Not otherwise classified, antineoplastic drugs

object_name: HPV positive oropharyngeal squamous cell carcinoma


subject: UMLS:C0499161

object_name: Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UMLS:C0499161

object_name: Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UMLS:C0499161

object_name: HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Clinical Stage


subject: UMLS:C0499161

object_name: Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UMLS:C0499161

object_name: HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Stage


subject: UMLS:C0499161

object_name: human papillomavirus-related squamous cell carcinoma


subject: UMLS:C0499161

object_name: Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UMLS:C0499161

object_name: Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UMLS:C0499161

object_name: Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UMLS:C0499161

object_name: HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma by AJCC v8 Pathologic Stage


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: Stevens-Johnson syndrome


subject: UMLS:C0085297

object_name: Stevens-Johnson Syndrome, CTCAE


subject: UMLS:C0085297

object_name: toxic epidermal necrolysis


subject: UMLS:C0085297

object_name: Toxic Epidermal Necrolysis, CTCAE


subject: CHEBI:50859

subject_name: Bexarotene

object_name: Childhood Breast Carcinoma


subject: CHEBI:50859

object_name: breast carcinoma


subject: CHEBI:50859

object_name: breast cancer


subject: CHEBI:9667

subject_name: Triamcinolone

object_name: Branch retinal vein occlusion


subject: RXCUI:1721613

subject_name: cobicistat 150 MG / elvitegravir 150 MG / emtricitabine 200 MG / tenofovir alafenamide 10 MG Oral Tablet

object_name: HIV-1 infection


subject: CHEBI:35341

subject_name: steroid

object_name: Dyssomnias


subject: CHEBI:35341

object_name: Sleep abnormality


subject: CHEBI:35341

object_name: sleep disorder


subject: CHEBI:2948

subject_name: Azathioprine


subject: UMLS:C0301532

subject_name: Multivitamin preparation

object_name: Light for dates


subject: CHEBI:6704

subject_name: Mebendazole

object_name: anemia


subject: CHEBI:6704

object_name: Anemia, CTCAE


subject: CHEBI:6704


subject: UMLS:C5575107

subject_name: furmonertinib mesylate

object_name: lung cancer


subject: UMLS:C5575107

object_name: lung neoplasm


subject: UMLS:C5575107

object_name: lung carcinoma


subject: CHEBI:6801

subject_name: Metformin

object_name: perinatal asphyxia


subject: CHEBI:6801

object_name: Neonatal hypoxic and ischemic brain injury


subject: CHEBI:6801

object_name: Hypoxic-Ischemic Encephalopathy


subject: CHEBI:6801

object_name: Hypoxic Ischemic Encephalopathy, AE


subject: CHEBI:6801

object_name: Hyper IgE


subject: UMLS:C2981856

subject_name: BNC 105P

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C2981856

object_name: clear cell renal carcinoma


subject: UMLS:C2981856

object_name: renal cell adenocarcinoma


subject: UMLS:C2981856

object_name: renal cell carcinoma


subject: CHEBI:71219

subject_name: Pazopanib

object_name: estrogen-receptor positive breast cancer


subject: CHEBI:71219

object_name: male breast carcinoma


subject: CHEBI:71219

object_name: Breast cancer stage II


subject: CHEBI:71219

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:71219

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:71219

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:71219

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:71219

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:71219

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:71219

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:71219

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:71219

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:71219

object_name: Her2-receptor negative breast cancer


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: non-small cell lung carcinoma


subject: CHEBI:16796

subject_name: Melatonin


subject: GTOPDB:4934

subject_name: G-CSF

object_name: early T cell progenitor acute lymphoblastic leukemia


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:91512


subject: PUBCHEM.COMPOUND:3628

subject_name: homoharringtonine


subject: CHEBI:71019

subject_name: omacetaxine


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:16586

subject_name: Aminocaproic acid

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:16586

object_name: thrombocytopenia


subject: UMLS:C0002525

subject_name: Amino Acids, Essential

object_name: osteoarthritis


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: prostate carcinoma


subject: CHEBI:8228

object_name: prostate cancer


subject: CHEBI:8228

object_name: Androgen insufficiency


subject: CHEBI:194186

subject_name: Tirzepatide

object_name: Endometrial Intraepithelial Neoplasia


subject: CHEBI:194186

object_name: FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma


subject: PUBCHEM.COMPOUND:133604

subject_name: Collagen

object_name: Foot Ulcer


subject: PUBCHEM.COMPOUND:133604

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:133604

object_name: Diabetes


subject: PUBCHEM.COMPOUND:133604

object_name: diabetes mellitus


subject: KEGG.COMPOUND:C00211


subject: KEGG.COMPOUND:C00211


subject: KEGG.COMPOUND:C00211


subject: KEGG.COMPOUND:C00211


subject: CHEBI:3815


subject: CHEBI:3815


subject: CHEBI:3815


subject: CHEBI:3815


subject: UMLS:C0009325

subject_name: collagen


subject: UMLS:C0009325


subject: UMLS:C0009325


subject: UMLS:C0009325


subject: CHEBI:66964

subject_name: Dronabinol

object_name: pregnancy related


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Postoperative Pain, Acute


subject: CHEBI:46195

object_name: Glenoid Labral Tears


subject: CHEBI:39585

subject_name: Carbidopa

object_name: opioid use


subject: CHEBI:39585

object_name: Chronic pain


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol


subject: CHEBI:6129

subject_name: Ketorolac

object_name: retinal detachment


subject: CHEBI:6129

object_name: Retinal Detachment, CTCAE 3.0


subject: CHEBI:6129

object_name: Retinal Detachment, CTCAE 5.0


subject: CHEBI:6129

object_name: blindness


subject: UMLS:C5966460

subject_name: Refresh Tears

object_name: retinopathy of prematurity


subject: UMLS:C5966460

object_name: exudative vitreoretinopathy 1


subject: UMLS:C5966460

object_name: Retinopathy of Prematurity, AE


subject: UMLS:C5966460


subject: UMLS:C5966460


subject: UMLS:C5966460


subject: UMLS:C5966460


subject: CHEBI:83766

subject_name: Olaparib

object_name: Metastatic Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:83766

object_name: Recurrent Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:83766

object_name: Unresectable Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:83766

object_name: Metastatic Gastric Carcinoma


subject: CHEBI:83766

object_name: recurrent gastric cancer


subject: CHEBI:83766

object_name: Unresectable Gastric Carcinoma


subject: CHEBI:83766

object_name: Unresectable Esophageal Carcinoma


subject: CHEBI:83766

object_name: Metastatic Esophageal Carcinoma


subject: CHEBI:83766

object_name: Oesophageal carcinoma recurrent


subject: CHEBI:83766

object_name: Malignant neoplasm of stomach stage III


subject: CHEBI:83766

object_name: Stage III Esophageal Cancer AJCC v7


subject: CHEBI:83766

object_name: Stage IV Esophageal Cancer AJCC v7


subject: CHEBI:83766

object_name: Malignant neoplasm of stomach stage IV


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab


subject: UNII:D99YVK4L0X


subject: UNII:D99YVK4L0X


subject: UNII:D99YVK4L0X


subject: UNII:D99YVK4L0X


subject: UNII:D99YVK4L0X


subject: UNII:D99YVK4L0X


subject: UNII:D99YVK4L0X


subject: UNII:D99YVK4L0X


subject: UNII:D99YVK4L0X


subject: UMLS:C1721684

subject_name: lexatumumab


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: CHEBI:9434

subject_name: Telmisartan

object_name: HIV-1 infection


subject: UMLS:C0058817

subject_name: Duraphat

object_name: dental caries


subject: CHEBI:94295

subject_name: Darinaparsin

object_name: liver carcinoma


subject: UMLS:C5432367


subject: UMLS:C0086333

subject_name: Gammagard

object_name: chronic kidney disease


subject: UMLS:C0086333

object_name: Chronic uremia


subject: UNII:K911R84KEW

subject_name: Margetuximab

object_name: metastatic neoplasm


subject: UNII:K911R84KEW

object_name: Embolism, Tumor


subject: UNII:K911R84KEW

object_name: Neoplasm Metastasis


subject: UMLS:C2984521

subject_name: MGAH22 antibody


subject: UMLS:C2984521


subject: UMLS:C2984521


subject: UNII:F85N2YHE4E

subject_name: Omega-3-carboxylic acids

object_name: type 2 diabetes mellitus


subject: UNII:F85N2YHE4E

object_name: exocrine pancreatic insufficiency


subject: PUBCHEM.COMPOUND:9831414

subject_name: Lovaza


subject: UNII:D87YGH4Z0Q

subject_name: Omacor


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone

object_name: Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL3990008

subject_name: TABELECLEUCEL

object_name: lymphoproliferative syndrome


subject: CHEMBL.COMPOUND:CHEMBL3990008

object_name: complications of organ transplant stem cells


subject: CHEMBL.COMPOUND:CHEMBL3990008

object_name: Lymphoma, AIDS-Related


subject: CHEMBL.COMPOUND:CHEMBL3990008

object_name: leiomyosarcoma


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: skin angiosarcoma


subject: CHEBI:72317

object_name: Visceral Angiosarcoma


subject: CHEBI:72317

object_name: Skin Radiation-Related Angiosarcoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: metastatic malignant neoplasm in the brain


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: Muscular autoimmune disorders


subject: MESH:C000629782

subject_name: talimogene laherparepvec

object_name: squamous cell carcinoma


subject: MESH:C000629782

object_name: Neck Carcinoma


subject: MESH:C000629782

object_name: head and neck neoplasm


subject: MESH:C000629782

object_name: head and neck cancer


subject: UNII:07730V90L6

subject_name: Talimogene laherparepvec


subject: UNII:07730V90L6


subject: UNII:07730V90L6


subject: UNII:07730V90L6


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: aneurysmal bone cyst


subject: UNII:4EQZ6YO2HI

object_name: giant cell reparative granuloma


subject: UNII:4EQZ6YO2HI

object_name: chondromyxoid fibroma


subject: UNII:4EQZ6YO2HI

object_name: chondroblastoma


subject: UNII:4EQZ6YO2HI

object_name: osteoblastoma


subject: UMLS:C1530450

subject_name: AMG 162


subject: UMLS:C1530450


subject: UMLS:C1530450


subject: UMLS:C1530450


subject: UMLS:C1530450


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: coronary aneurysm


subject: CHEBI:68579

object_name: Coronary Artery Aneurysm Related to COVID-19


subject: CHEBI:68579

object_name: mucocutaneous lymph node syndrome


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: essential hypertension


subject: CHEBI:9434

subject_name: Telmisartan

object_name: cardiovascular disorder


subject: CHEBI:83527

subject_name: Desvenlafaxine

object_name: Depressed mood


subject: CHEBI:83527

object_name: Cancer patients and suicide and depression


subject: CHEBI:83527

object_name: Depressed - symptom


subject: CHEBI:83527

object_name: Depression, CTCAE


subject: MESH:C558471

subject_name: Hizentra

object_name: chronic inflammatory demyelinating polyradiculoneuropathy


subject: MESH:C558471

object_name: Guillain-Barre syndrome, familial


subject: CHEBI:205919

subject_name: Clobetasol

object_name: Skin and Connective Tissue Diseases


subject: CHEBI:2955

subject_name: Azithromycin

object_name: post operative nausea and vomiting


subject: CHEBI:172923

subject_name: FLUORESCEIN

object_name: adult glioblastoma


subject: UMLS:C0591527

subject_name: Fluorets


subject: GTOPDB:13187

subject_name: camoteskimab

object_name: atopy


subject: GTOPDB:13187

object_name: atopic eczema


subject: GTOPDB:13187

object_name: dermatitis


subject: GTOPDB:13187

object_name: Dermatitis


subject: GTOPDB:13187

object_name: atopic eczema/dermatitis (non-specific)


subject: GTOPDB:13187

object_name: skin disorder


subject: GTOPDB:13187

object_name: Eczema, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL2109604

subject_name: CAMOTESKIMAB


subject: CHEMBL.COMPOUND:CHEMBL2109604


subject: CHEMBL.COMPOUND:CHEMBL2109604


subject: CHEMBL.COMPOUND:CHEMBL2109604


subject: CHEMBL.COMPOUND:CHEMBL2109604


subject: CHEMBL.COMPOUND:CHEMBL2109604


subject: CHEMBL.COMPOUND:CHEMBL2109604


subject: UMLS:C5555534


subject: UMLS:C5555534


subject: UMLS:C5555534


subject: UMLS:C5555534


subject: UMLS:C5555534


subject: UMLS:C5555534


subject: UMLS:C5555534


subject: DRUGBANK:DB04973

subject_name: LErafAON

object_name: neoplasm


subject: UNII:4FR53SIF3A

subject_name: Blinatumomab

object_name: Non-Hodgkin's lymphoma refractory


subject: UNII:4FR53SIF3A

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: UNII:4FR53SIF3A

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: UNII:4FR53SIF3A

object_name: Recurrent Non-Hodgkin Lymphoma


subject: UNII:4FR53SIF3A

object_name: Burkitt's lymphoma refractory


subject: UNII:4FR53SIF3A

object_name: Refractory Gray-Zone Lymphoma


subject: UNII:4FR53SIF3A

object_name: Mantle cell lymphoma refractory


subject: UNII:4FR53SIF3A

object_name: Follicular lymphoma refractory


subject: UNII:4FR53SIF3A

object_name: Refractory Mediastinal Lymphoma


subject: UNII:4FR53SIF3A

object_name: Marginal zone lymphoma refractory


subject: UNII:4FR53SIF3A

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: UNII:4FR53SIF3A

object_name: B-cell small lymphocytic lymphoma refractory


subject: UNII:4FR53SIF3A

object_name: Refractory Grade 3a Follicular Lymphoma


subject: UNII:4FR53SIF3A

object_name: Refractory Grade 2 Follicular Lymphoma


subject: UNII:4FR53SIF3A

object_name: Refractory Grade 3 Follicular Lymphoma


subject: UNII:4FR53SIF3A

object_name: Refractory Grade 1 Follicular Lymphoma


subject: UNII:4FR53SIF3A

object_name: Mantle cell lymphoma recurrent


subject: UNII:4FR53SIF3A

object_name: Recurrent Burkitt Lymphoma


subject: UNII:4FR53SIF3A

object_name: Recurrent Childhood Burkitt Lymphoma


subject: UNII:4FR53SIF3A

object_name: Recurrent Adult Burkitt Lymphoma


subject: UNII:4FR53SIF3A

object_name: Recurrent Gray-Zone Lymphoma


subject: UNII:4FR53SIF3A

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UNII:4FR53SIF3A

object_name: Recurrent Mediastinal Lymphoma


subject: UNII:4FR53SIF3A

object_name: Marginal zone lymphoma recurrent


subject: UNII:4FR53SIF3A

object_name: Diffuse large B-cell lymphoma recurrent


subject: UNII:4FR53SIF3A

object_name: Recurrent Grade 3a Follicular Lymphoma


subject: UNII:4FR53SIF3A

object_name: Recurrent Grade 3b Follicular Lymphoma


subject: UNII:4FR53SIF3A

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: UNII:4FR53SIF3A

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: UNII:4FR53SIF3A

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Refractory Mediastinal Lymphoma


subject: CHEBI:63791

object_name: Refractory Grade 3a Follicular Lymphoma


subject: CHEBI:63791

object_name: Refractory Grade 2 Follicular Lymphoma


subject: CHEBI:63791

object_name: Refractory Grade 3 Follicular Lymphoma


subject: CHEBI:63791

object_name: Refractory Grade 1 Follicular Lymphoma


subject: CHEBI:63791


subject: DRUGBANK:DB15803

subject_name: Dendritic cells vaccine

object_name: prostate carcinoma


subject: DRUGBANK:DB15803

object_name: prostate cancer


subject: UMLS:C5782830

subject_name: ROPivacaine 0.5% injectable solution

object_name: osteoarthritis, knee


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: hypoglycemia


subject: CHEBI:85078

object_name: Blood glucose below reference range (finding)


subject: CHEBI:85078

object_name: Hypoglycemia, CTCAE


subject: CHEBI:85078

object_name: Loss of hypoglycemic warning due to diabetes mellitus


subject: CHEBI:52993

subject_name: Lormetazepam

object_name: endogenous depression


subject: CHEBI:52993

object_name: major depressive disorder


subject: CHEBI:6539

subject_name: Lorazepam


subject: CHEBI:6539


subject: CHEBI:7915

subject_name: Pantoprazole

object_name: Drug Interactions


subject: CHEBI:7915

object_name: Adverse drug interaction


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: Atrophic endometrium


subject: CHEBI:150712

object_name: Uterine hemorrhage


subject: CHEBI:150712

object_name: uterine polyp


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEBI:23965

subject_name: estradiol


subject: CHEBI:23965


subject: UMLS:C4321475

subject_name: Ceramide Nanoliposome

object_name: Solid Neoplasm


subject: UMLS:C4321475

object_name: neoplasm


subject: UMLS:C4321475

object_name: Tumor Mass


subject: UMLS:C4321475

object_name: cancer


subject: UMLS:C4321475

object_name: carcinoma


subject: GTOPDB:11376

subject_name: bintrafusp alfa

object_name: metastatic malignant neoplasm in the brain


subject: GTOPDB:11376

object_name: metastatic melanoma


subject: GTOPDB:11376

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: GTOPDB:11376

object_name: hematopoietic and lymphoid cell neoplasm


subject: GTOPDB:11376

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: GTOPDB:11376

object_name: Metastatic Malignant Solid Neoplasm


subject: GTOPDB:11376

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: GTOPDB:11376

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL4298024

subject_name: BINTRAFUSP ALFA


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: CHEBI:94793

subject_name: Pimasertib


subject: CHEBI:94793

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:94793

object_name: Stage IVA Lung Cancer AJCC v8


subject: CHEBI:94793

object_name: Stage IVB Lung Cancer AJCC v8


subject: CHEBI:94793

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:94793

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:94793


subject: CHEBI:94793


subject: CHEBI:94793

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: CHEBI:94793


subject: CHEBI:94793


subject: CHEBI:94793


subject: CHEBI:94793

object_name: Hormone Receptor-Positive Breast Carcinoma


subject: CHEBI:94793


subject: CHEBI:94793


subject: UNII:RM4GJT3SMQ

subject_name: Selgantolimod

object_name: chronic hepatitis B virus infection


subject: UNII:RM4GJT3SMQ

object_name: hepatitis B


subject: PUBCHEM.COMPOUND:160283094

subject_name: ZONGERTINIB

object_name: liver disorder


subject: UNII:DRH7R67UVL


subject: UMLS:C5907906

subject_name: HER-2 Inhibitor BI 1810631


subject: UMLS:C0005525

subject_name: Biological Response Modifiers

object_name: asthma


subject: UMLS:C4287699

subject_name: TPIV 200

object_name: ovarian cancer


subject: UMLS:C4287699

object_name: ovarian neoplasm


subject: UMLS:C4287699

object_name: ovarian carcinoma


subject: UMLS:C4743433

subject_name: onabotulinum toxin A

object_name: Upper limb spasticity


subject: UMLS:C5544584

subject_name: Optate


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: allergic bronchopulmonary aspergillosis


subject: UMLS:C3658854


subject: UMLS:C5226926

object_name: Malignant Solid Neoplasm


subject: UMLS:C5226926

object_name: plasma cell myeloma


subject: UMLS:C5226926

object_name: adult lymphoma


subject: UMLS:C5226926

object_name: lymphoma


subject: UMLS:C5226926

object_name: pediatric lymphoma


subject: CHEBI:134709

subject_name: Pitolisant

object_name: myotonic dystrophy type 1


subject: CHEBI:134709

object_name: myotonic dystrophy


subject: UMLS:C2699335

subject_name: cixutumumab

object_name: Recurrent Adrenal Cortical Carcinoma


subject: UMLS:C2699335

object_name: Stage IV Adrenal Cortex Carcinoma AJCC v7


subject: UMLS:C2699335

object_name: Stage IV Adrenal Cortex Carcinoma AJCC v8


subject: UMLS:C2699335

object_name: Stage III Adrenal Cortex Carcinoma AJCC v8


subject: UMLS:C2699335

object_name: Stage III Adrenal Cortex Carcinoma AJCC v7


subject: CHEBI:6954

subject_name: Mitotane


subject: CHEBI:6954


subject: CHEBI:6954


subject: CHEBI:6954


subject: CHEBI:6954


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: psoriasis


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEMBL.COMPOUND:CHEMBL1743006

subject_name: DALOTUZUMAB

object_name: breast neoplasm


subject: UMLS:C2987605

subject_name: dalotuzumab


subject: CHEBI:68554

subject_name: Deferiprone

object_name: heart disorder


subject: CHEBI:68554

object_name: cardiovascular disorder


subject: UMLS:C0600472

subject_name: Long Interspersed Nucleotide Element-1

object_name: beta thalassemia


subject: UMLS:C0600472

object_name: beta-thalassemia HBB/LCRB


subject: UMLS:C0600472


subject: UMLS:C0600472


subject: UniProtKB:P03101

subject_name: VL1_HPV16 Major capsid protein L1 (sprot)


subject: UniProtKB:P03101


subject: UniProtKB:P03101


subject: UniProtKB:P03101


subject: UniProtKB:Q07860

subject_name: VL1_HPV04 Major capsid protein L1 (sprot)


subject: UniProtKB:Q07860


subject: UniProtKB:Q07860


subject: UniProtKB:Q07860


subject: PR:000029475

subject_name: CYFIP-related Rac1 interactor B


subject: PR:000029475


subject: PR:000029475


subject: PR:000029475


subject: UMLS:C0016004

subject_name: Beriplast P

object_name: Exsanguination


subject: CHEBI:6062

subject_name: Isosorbide mononitrate

object_name: Fetal or neonatal effect of induction of labor


subject: CHEBI:6062

object_name: Premature rupture of membranes


subject: PUBCHEM.COMPOUND:2863

object_name: plantar fasciitis


subject: CHEBI:16962

subject_name: Cortisone


subject: PUBCHEM.COMPOUND:11511576

subject_name: Tedizolid phosphate

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:11511576

object_name: obesity


subject: PUBCHEM.COMPOUND:11511576

object_name: Obesity, CTCAE


subject: CHEBI:82717

subject_name: Tedizolid


subject: CHEBI:82717


subject: CHEBI:82717


subject: GTOPDB:10659

subject_name: bempegaldesleukin

object_name: Metastatic Renal Cell Carcinoma


subject: GTOPDB:10659

object_name: Metastatic Renal Cell Cancer


subject: CHEMBL.COMPOUND:CHEMBL4298058

subject_name: BEMPEGALDESLEUKIN


subject: CHEMBL.COMPOUND:CHEMBL4298058


subject: UMLS:C4309517


subject: UMLS:C4309517


subject: UNII:3K6DN6EM76

object_name: neuralgia


subject: UNII:3K6DN6EM76

object_name: Neuralgia, CTCAE


subject: UMLS:C4329340

subject_name: Nisevokitug

object_name: Metastatic malignant neoplasm to pancreas


subject: UMLS:C4329340

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:94688

subject_name: Acipimox

object_name: bulimia nervosa


subject: CHEBI:94688

object_name: eating disorder


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Cutaneous Squamous Cell Carcinoma of the Head and Neck


subject: UMLS:C2346820


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: Non-ischaemic cardiomyopathy


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: CHEBI:81862

object_name: Age-related sarcopenia


subject: UMLS:C1883555

subject_name: Whey Protein Isolate

object_name: Muscle Atrophy


subject: UMLS:C1883555


subject: UMLS:C4688441

subject_name: Promenakin


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: Tumour thrombosis


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: CHEBI:63631

subject_name: Topiramate

object_name: sudden sensorineural hearing loss


subject: CHEBI:63631

object_name: Deafness, Sudden


subject: CHEBI:16240

subject_name: Hioxyl

object_name: Childhood Breast Carcinoma


subject: CHEBI:16240

object_name: breast carcinoma


subject: CHEBI:16240

object_name: breast cancer


subject: PUBCHEM.COMPOUND:77256380

subject_name: Glasdegib

object_name: juvenile myelomonocytic leukemia


subject: PUBCHEM.COMPOUND:77256380

object_name: Adult Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:77256380

object_name: childhood myelodysplastic syndrome


subject: PUBCHEM.COMPOUND:77256380

object_name: Myelodysplastic Syndrome, CTCAE


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: severe acute respiratory syndrome


subject: PR:000005931


subject: UNII:44Q500OSL4

subject_name: Pecavaptan

object_name: kidney failure


subject: UNII:44Q500OSL4

object_name: heart failure


subject: UNII:44Q500OSL4

object_name: congestive heart failure


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:521372

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:521372

object_name: Prostate cancer recurrent


subject: PUBCHEM.COMPOUND:521372

object_name: prostate adenocarcinoma


subject: CHEBI:36791

subject_name: Escitalopram

object_name: Inflammation


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Depressed mood


subject: CHEBI:41423

object_name: Cancer patients and suicide and depression


subject: CHEBI:41423

object_name: Depressed - symptom


subject: CHEBI:41423

object_name: Depression, CTCAE


subject: CHEBI:50169

subject_name: Brexanolone


subject: CHEBI:50169


subject: CHEBI:50169


subject: CHEBI:50169


subject: UNII:51M3FB9B9E

object_name: diabetic kidney disease


subject: PUBCHEM.COMPOUND:8230

subject_name: Argipressin

object_name: hypotension


subject: PUBCHEM.COMPOUND:8230

object_name: Hypotension, CTCAE


subject: UMLS:C1527128

subject_name: Recombinant Vasopressin


subject: UMLS:C1527128


subject: UMLS:C0003779

subject_name: argipressin


subject: UMLS:C0003779


subject: PUBCHEM.COMPOUND:56998

object_name: leishmaniasis


subject: UMLS:C4722543

subject_name: Toll-like Receptor 4 Agonist GLA-SE


subject: UMLS:C4722544

subject_name: Glucopyranosyl Lipid Adjuvant-Stable Emulsion


subject: CHEMBL.COMPOUND:CHEMBL4650404


subject: CHEBI:74813

subject_name: Ser-Glu


subject: PR:000015601

subject_name: squalene monooxygenase


subject: PR:000007705


subject: HMDB:HMDB0001349

subject_name: Selenium


subject: CHEBI:8871

subject_name: Risperidone

object_name: fish eye disease


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: Miscellaneous Peripheral Blood Cell Abnormalities


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:55438

subject_name: Angiotensin 1-7


subject: UMLS:C0103306


subject: CHEBI:38940

subject_name: Sunitinib

object_name: metastatic prostate carcinoma


subject: CHEBI:6456

subject_name: Lidocaine

object_name: tuberculosis


subject: CHEBI:8404

subject_name: Prilocaine


subject: CHEBI:189653

subject_name: pelabresib

object_name: peripheral nervous system neoplasm


subject: CHEBI:185135

subject_name: Polyvidone

object_name: methicillin-resistant staphylococcus aureus infectious disease


subject: CHEBI:8347

subject_name: Povidone-iodine


subject: UNII:WJA5UO9E10

subject_name: Orelabrutinib

object_name: EXCESS LMW-DNA


subject: CHEBI:32184

subject_name: Tazarotene

object_name: actinic keratosis


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C4684393

subject_name: Favezelimab


subject: UMLS:C5787244

subject_name: Coformulated MK-4280 Plus MK-3475

object_name: Solid Neoplasm


subject: UMLS:C5787244


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:7773

subject_name: Ondansetron

object_name: Sepsis


subject: CHEBI:7773

object_name: Sepsis, CTCAE


subject: CHEBI:7773

object_name: septic shock


subject: UMLS:C5235868

object_name: Childhood Solid Neoplasm


subject: UMLS:C5235868

object_name: Adult Solid Neoplasm


subject: UMLS:C5235868


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)

object_name: Breast cancer recurrent


subject: CHEBI:92607

subject_name: Methylergometrine

object_name: twin; complicating pregnancy


subject: PUBCHEM.COMPOUND:5458171

subject_name: MITOXANTRONE HYDROCHLORIDE

object_name: B-cell childhood acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:5458171

object_name: T-cell childhood acute lymphocytic leukemia


subject: PUBCHEM.COMPOUND:5458171

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:5458171

object_name: Recurrent Childhood Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:5458171

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: CHEBI:50729

subject_name: Mitoxantrone


subject: CHEBI:50729


subject: CHEBI:50729


subject: CHEBI:50729


subject: CHEBI:50729


subject: UNII:7D96IR0PPM

subject_name: Pegaspargase


subject: UNII:7D96IR0PPM


subject: CHEBI:79699

subject_name: Temsirolimus


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:79699


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:200105

subject_name: Glucovance

object_name: gestational diabetes


subject: MESH:C417231


subject: CHEBI:131168

subject_name: Afuresertib

object_name: Childhood Breast Carcinoma


subject: CHEBI:131168

object_name: breast carcinoma


subject: CHEBI:131168

object_name: breast cancer


subject: CHEBI:27446

subject_name: Penicillin V

object_name: plasma cell myeloma


subject: CHEBI:7956

subject_name: Penciclovir


subject: CHEBI:4356

subject_name: Deferoxamine

object_name: brain aneurysm


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: esophageal squamous cell carcinoma


subject: UNII:PQX0D8J21J

object_name: esophageal adenocarcinoma


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C5206716

object_name: colorectal cancer


subject: UMLS:C5206716

object_name: colorectal carcinoma


subject: UMLS:C5206716

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5206716

object_name: Stomach cancer


subject: UMLS:C5206716

object_name: gastric cancer


subject: UMLS:C5206716


subject: UMLS:C5206716


subject: UMLS:C5206716

object_name: liver carcinoma


subject: UMLS:C2348173

subject_name: GTx 024

object_name: Cachexia


subject: UMLS:C2987589

object_name: cervical intraepithelial neoplasia


subject: UMLS:C2987589

object_name: dysplasia of cervix


subject: UMLS:C2987589

object_name: adenocarcinoma in situ


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: cancer


subject: UNII:LKC0U3A8NJ

object_name: neoplasm


subject: UNII:LKC0U3A8NJ

object_name: arteriosclerosis disorder


subject: UNII:RCX0IE6EJZ

subject_name: Leflutrozole

object_name: hypogonadotropic hypogonadism


subject: UNII:RCX0IE6EJZ

object_name: Klinefelter syndrome


subject: CHEBI:49040

subject_name: Ezetimibe

object_name: hypercholesterolemia, familial, 1


subject: CHEBI:49040

object_name: familial hypercholesterolemia


subject: CHEBI:9150

subject_name: Simvastatin


subject: UNII:8L7891MRB6

subject_name: Encorafenib

object_name: hairy cell leukemia


subject: CHEBI:145371

subject_name: Binimetinib


subject: CHEBI:24848

subject_name: inositol

object_name: Menopausal syndrome


subject: CHEBI:24848

object_name: Menopause present (finding)


subject: CHEBI:24848

object_name: Menopause


subject: CHEBI:76989

subject_name: phytoestrogen

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:76989

object_name: metabolic syndrome X


subject: CHEBI:76989


subject: CHEBI:76989


subject: CHEBI:76989


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: pure red-cell aplasia


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:35475

subject_name: non-steroidal anti-inflammatory drug

object_name: breast neoplasm


subject: UMLS:C0003211

subject_name: Anti-Inflammatory Agents, Non-Steroidal


subject: UMLS:C0358845

subject_name: Analgesics and non-steroidal anti-inflammatory drugs


subject: CHEBI:6129

subject_name: Ketorolac


subject: CHEBI:132922


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: UMLS:C0935965

object_name: non-small cell lung carcinoma


subject: CHEBI:34650

subject_name: COLISTIMETHATE

object_name: Hospital acquired pneumonia


subject: CHEBI:37943

subject_name: colistin


subject: CHEBI:178199

subject_name: Sotorasib

object_name: colorectal carcinoma


subject: MESH:C097921

object_name: brain cancer


subject: MESH:C097921

object_name: brain neoplasm


subject: CHEBI:50819

subject_name: Ferric oxide


subject: CHEBI:50819


subject: UMLS:C0754268

subject_name: Combidex


subject: UMLS:C0754268


subject: CHEBI:35674

subject_name: antihypertensive agent

object_name: aneurysm


subject: CHEBI:35674

object_name: heart disorder


subject: UMLS:C0003364

subject_name: Antihypertensive Agents


subject: UMLS:C0003364


subject: CHEBI:231353

subject_name: Orteronel

object_name: Carcinoma breast stage IV


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: Locally Advanced Unresectable Triple-Negative Breast Carcinoma


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: CHEBI:41774


subject: UNII:05HYK3CV9N

subject_name: Linperlisib

object_name: adult pure red cell aplasia


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Neonatal Late-Onset Sepsis


subject: UNII:1C6V77QF41

object_name: Neonatal rickets


subject: UNII:1C6V77QF41

object_name: Osteopenia of prematurity


subject: UNII:1C6V77QF41

object_name: nephrolithiasis


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: UMLS:C5678728

subject_name: testosterone pellets

object_name: Peyronie disease


subject: PUBCHEM.COMPOUND:3249

subject_name: VITAMIN D2


subject: CHEBI:27300


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:71954

subject_name: Buparlisib

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:71954

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:71954

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:71954

object_name: estrogen-receptor positive breast cancer


subject: CHEBI:71954

object_name: Breast cancer recurrent


subject: UMLS:C0304229

subject_name: Experimental drug

object_name: Metastatic malignant neoplasm to pancreas


subject: UMLS:C5959090

subject_name: Anti-CEA/Anti-4-1BB Bispecific Antibody LM-24C5

object_name: Advanced Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:71308244

subject_name: Naldemedine

object_name: cancer


subject: PUBCHEM.COMPOUND:71308244

object_name: neoplasm


subject: CHEBI:47426

subject_name: Furosemide

object_name: Drug usage


subject: CHEBI:47426

object_name: Drug use history


subject: CHEBI:47426

object_name: Encounter due to drug use


subject: CHEBI:4356

subject_name: Deferoxamine


subject: UNII:BLP1XA3FZA

subject_name: Venglustat

object_name: autosomal dominant polycystic kidney disease


subject: UMLS:C0071315

subject_name: Pneumovax

object_name: Crohn disease


subject: RXCUI:901639

subject_name: Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine Prefilled Syringe


subject: UMLS:C0003233

subject_name: Antibiotics, Aminoglycoside

object_name: cystic fibrosis


subject: UMLS:C0003233

object_name: Cystic fibrosis pulmonary exacerbation


subject: CHEBI:47779

subject_name: aminoglycoside


subject: CHEBI:47779


subject: UMLS:C3536835

subject_name: Aminoglycoside [EPC]


subject: UMLS:C3536835


subject: CHEBI:50695

subject_name: monobactam


subject: CHEBI:50695


subject: CHEBI:27933

subject_name: beta-lactam antibiotic


subject: CHEBI:27933


subject: CHEBI:230905

subject_name: Ribociclib

object_name: head and neck squamous cell carcinoma


subject: CHEBI:94534

subject_name: olanzapine

object_name: Negative symptoms in schizophrenia


subject: CHEBI:8869

subject_name: Risedronic acid

object_name: hyperparathyroidism


subject: CHEBI:8869

object_name: Hyperparathyroidism, CTCAE


subject: CHEBI:8869

object_name: vitamin D deficiency


subject: CHEBI:8869

object_name: rickets


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: CHEBI:89324


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: CHEBI:26607

subject_name: saturated fatty acid

object_name: cardiovascular disorder


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: Pelvis fracture


subject: UNII:6XC1PAD3KF

object_name: Hip Fracture, CTCAE


subject: UNII:6XC1PAD3KF

object_name: hip fracture


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: CHEBI:4469

subject_name: dexamfetamine

object_name: schizoaffective disorder


subject: CHEBI:4469

object_name: schizophrenia 18


subject: CHEBI:6801

subject_name: Metformin

object_name: alopecia areata


subject: CHEBI:6801

object_name: alopecia


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: traumatic encephalopathy


subject: CHEBI:94518

object_name: traumatic brain injury


subject: UMLS:C4721781

subject_name: Tedopi

object_name: non-small cell lung carcinoma


subject: CHEBI:193615

object_name: Benign neoplasm of liver


subject: CHEBI:193615

object_name: Liver problem


subject: CHEBI:193615

object_name: nasopharyngeal carcinoma


subject: CHEBI:193615

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEBI:60761

subject_name: Floxuridine


subject: CHEBI:60761


subject: CHEBI:60761


subject: CHEBI:60761


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:52172

subject_name: Nilotinib

object_name: pulmonary hypertension, primary, 1


subject: CHEBI:52172

object_name: pulmonary hypertension


subject: CHEBI:52172

object_name: idiopathic pulmonary arterial hypertension


subject: CHEBI:52172

object_name: pulmonary arterial hypertension


subject: PUBCHEM.COMPOUND:130770

object_name: Acute Pain


subject: PUBCHEM.COMPOUND:435949

subject_name: IV

object_name: influenza


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:9139

subject_name: Sildenafil

object_name: Associated Pulmonary Arterial Hypertension


subject: CHEBI:9449

subject_name: Terbutaline

object_name: autoimmune thrombocytopenia


subject: CHEBI:9449

object_name: thrombocytopenia due to immune destruction


subject: CHEBI:9449

object_name: autoimmune thrombocytopenic purpura


subject: CHEBI:71940

subject_name: Tadalafil


subject: CHEBI:71940

object_name: Secondary malignant neoplasm of lung


subject: CHEBI:71940

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:71940

object_name: lung cancer


subject: CHEBI:71940

object_name: lung neoplasm


subject: CHEBI:71940

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:105162

object_name: childhood neoplasm


subject: PUBCHEM.COMPOUND:105162

object_name: neoplastic syndrome


subject: PUBCHEM.COMPOUND:105162

object_name: cancer or benign tumor


subject: PUBCHEM.COMPOUND:105162

object_name: neoplasm


subject: UNII:FB9L37AF2L


subject: UNII:FB9L37AF2L


subject: UNII:FB9L37AF2L


subject: UNII:FB9L37AF2L


subject: CHEBI:151

subject_name: ISOCITRIC ACID

object_name: metastatic melanoma


subject: CHEBI:151

object_name: Unresectable Melanoma


subject: CHEBI:151


subject: CHEBI:41879

object_name: Langerhans cell histiocytosis


subject: CHEBI:229764

subject_name: Selinexor


subject: UNII:A3ULP0F556

subject_name: Eculizumab

object_name: Autoimmunity


subject: UNII:V038D626IF

subject_name: Ashwagandha

object_name: periodontitis, chronic, adult


subject: UNII:V038D626IF

object_name: chronic periodontitis


subject: CHEBI:231342

subject_name: ceralasertib

object_name: Advanced Colorectal Carcinoma


subject: CHEBI:231342

object_name: Stage IV Colorectal Cancer AJCC v8


subject: CHEBI:231342

object_name: Advanced Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:231342

object_name: Stage III Colorectal Cancer AJCC v8


subject: CHEBI:231342

object_name: Unresectable Colorectal Carcinoma


subject: CHEBI:231342

object_name: Advanced gastric carcinoma


subject: CHEBI:231342

object_name: Metastatic Colorectal Carcinoma


subject: CHEBI:231342

object_name: Metastatic Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:231342

object_name: Unresectable Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:231342

object_name: Advanced Colon Carcinoma


subject: CHEBI:231342

object_name: Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:231342

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:231342

object_name: Advanced Endometrial Carcinoma


subject: CHEBI:231342

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:231342

object_name: Advanced Salivary Gland Carcinoma


subject: CHEBI:231342

object_name: HER2 positive breast carcinoma


subject: CHEBI:231342

object_name: Stage IV Colon Cancer AJCC v8


subject: CHEBI:231342

object_name: Unresectable Endometrial Carcinoma


subject: CHEBI:231342

object_name: Stage III Colon Cancer AJCC v8


subject: CHEBI:231342

object_name: Clinical Stage IV Gastric Cancer AJCC v8


subject: CHEBI:231342

object_name: Clinical Stage III Gastric Cancer AJCC v8


subject: CHEBI:231342

object_name: Metastatic Endometrial Carcinoma


subject: CHEBI:231342

object_name: Unresectable Colon Carcinoma


subject: CHEBI:231342

object_name: Unresectable Malignant Solid Neoplasm


subject: CHEBI:231342

object_name: Stage IV Major Salivary Gland Cancer AJCC v8


subject: CHEBI:231342

object_name: Stage III Major Salivary Gland Cancer AJCC v8


subject: CHEBI:231342

object_name: Stage III Uterine Corpus Cancer AJCC v8


subject: CHEBI:231342

object_name: Unresectable Gastric Carcinoma


subject: CHEBI:231342

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: CHEBI:231342

object_name: Unresectable Salivary Gland Carcinoma


subject: CHEBI:231342

object_name: Metastatic Gastric Carcinoma


subject: CHEBI:231342

object_name: Metastatic Salivary Gland Carcinoma


subject: CHEBI:231342

object_name: Unresectable Breast Carcinoma


subject: CHEBI:231342

object_name: Metastatic Colon Carcinoma


subject: CHEBI:231342

object_name: Malignant hepatobiliary neoplasms


subject: UNII:SE2KH7T06F

object_name: Advanced Colorectal Carcinoma


subject: UNII:SE2KH7T06F

object_name: Stage IV Colorectal Cancer AJCC v8


subject: UNII:SE2KH7T06F

object_name: Advanced Gastroesophageal Junction Adenocarcinoma


subject: UNII:SE2KH7T06F

object_name: Stage III Colorectal Cancer AJCC v8


subject: UNII:SE2KH7T06F

object_name: Unresectable Colorectal Carcinoma


subject: UNII:SE2KH7T06F

object_name: Metastatic Colorectal Carcinoma


subject: UNII:SE2KH7T06F

object_name: Advanced Colon Carcinoma


subject: UNII:SE2KH7T06F

object_name: Advanced Endometrial Carcinoma


subject: UNII:SE2KH7T06F

object_name: Advanced Salivary Gland Carcinoma


subject: UNII:SE2KH7T06F

object_name: Unresectable Endometrial Carcinoma


subject: UNII:SE2KH7T06F

object_name: Unresectable Colon Carcinoma


subject: UNII:SE2KH7T06F

object_name: Stage III Uterine Corpus Cancer AJCC v8


subject: UNII:SE2KH7T06F

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766

object_name: Advanced gastric carcinoma


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766

object_name: Stage IV Colon Cancer AJCC v8


subject: UMLS:C4287766


subject: UMLS:C4287766

object_name: Stage III Colon Cancer AJCC v8


subject: UMLS:C4287766

object_name: Metastatic Endometrial Carcinoma


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766

object_name: Metastatic Colon Carcinoma


subject: UMLS:C4287766

object_name: Malignant hepatobiliary neoplasms


subject: CHEBI:3647

subject_name: Chlorpromazine

object_name: Stage III Colon Cancer


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Nail psoriasis


subject: CHEBI:74705

object_name: nail disorder


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: UNII:5W6YA9PKKH

subject_name: INDINAVIR

object_name: tuberculosis


subject: CHEBI:44032

subject_name: Indinavir


subject: CHEBI:32428

subject_name: cetoleic acid

object_name: Diet, Healthy


subject: CHEBI:180019

subject_name: Catelaidic acid


subject: PUBCHEM.COMPOUND:122316

object_name: schizophrenia


subject: CHEBI:63620

subject_name: Rasagiline


subject: CHEBI:6532

subject_name: Loperamide

object_name: Drug Interactions


subject: CHEBI:6532

object_name: Adverse drug interaction


subject: UMLS:C1449659

subject_name: 4-Aminopyridine Sustained Release

object_name: Cognitive fatigue


subject: UMLS:C0453260

subject_name: ginger root

object_name: colorectal cancer


subject: UMLS:C0453260

object_name: colorectal carcinoma


subject: UMLS:C0453260

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:16581

subject_name: Pregnenolone

object_name: pervasive developmental disorder


subject: CHEBI:16581

object_name: autism spectrum disorder


subject: PUBCHEM.COMPOUND:46874763

object_name: Sting Injury


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C4271000

subject_name: Pain Relieving Cream


subject: CHEMBL.COMPOUND:CHEMBL5095455

subject_name: DAPLUSIRAN

object_name: hepatitis B


subject: CHEMBL.COMPOUND:CHEMBL5095455

object_name: chronic hepatitis B virus infection


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: Fractured shoulder


subject: UNII:8Y1C6K0PCA

subject_name: DOC

object_name: nasopharyngeal carcinoma


subject: UNII:8Y1C6K0PCA

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEBI:16973

subject_name: desoxycortone


subject: CHEBI:16973


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Acute Stroke


subject: UMLS:C1527137

object_name: Ischemic stroke


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: CHEBI:95067

subject_name: Iniparib

object_name: ovarian cancer


subject: CHEBI:95067

object_name: ovarian neoplasm


subject: CHEBI:95067

object_name: ovarian carcinoma


subject: UMLS:C1831868

subject_name: BSI 201


subject: UMLS:C1831868


subject: UMLS:C1831868


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: immunoglobulin G4-related sclerosing disease


subject: CHEBI:63791

object_name: Immunoglobulin G4-Related Disease


subject: CHEBI:63791

object_name: IgG4-related sclerosing cholangitis


subject: CHEBI:63791

object_name: autoimmune pancreatitis


subject: CHEBI:63791

object_name: IgG4-related retroperitoneal fibrosis


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: PUBCHEM.COMPOUND:77014446

subject_name: Ketofol

object_name: Depressed mood


subject: PUBCHEM.COMPOUND:77014446

object_name: Cancer patients and suicide and depression


subject: PUBCHEM.COMPOUND:77014446

object_name: Depressed - symptom


subject: PUBCHEM.COMPOUND:77014446

object_name: Depression, CTCAE


subject: PUBCHEM.COMPOUND:77014446

object_name: self-limited epilepsy with centrotemporal spikes


subject: CHEBI:102216

subject_name: Methohexital


subject: PUBCHEM.COMPOUND:4739

subject_name: Vidarbine

object_name: Mesothelioma


subject: PUBCHEM.COMPOUND:4739

object_name: mesothelial neoplasm


subject: PUBCHEM.COMPOUND:4739

object_name: malignant mesothelioma


subject: PUBCHEM.COMPOUND:4739

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:4739

object_name: lung adenocarcinoma


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:27834

subject_name: Pentostatin


subject: CHEBI:27834


subject: CHEBI:27834


subject: CHEBI:27834


subject: CHEBI:27834


subject: CHEBI:31215

subject_name: anecortave

object_name: Chronic central serous chorioretinopathy


subject: CHEBI:25105

subject_name: macrolide antibiotic

object_name: COPD, severe early onset


subject: CHEBI:25105

object_name: chronic obstructive pulmonary disease


subject: UMLS:C0003240

subject_name: Macrolide Antibiotics


subject: UMLS:C0003240


subject: UMLS:C1254351

subject_name: Pharmacologic Substance

object_name: metastatic melanoma


subject: UMLS:C1330568

subject_name: TriNessa

object_name: Uses contraception (finding)


subject: CHEMBL.COMPOUND:CHEMBL1187846

subject_name: SCOPOLAMINE

object_name: motion sickness


subject: KEGG.COMPOUND:C01851

subject_name: Scopolamine


subject: CHEBI:91541


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: Inflammation


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN

object_name: neoplasm


subject: CHEBI:176724

subject_name: Etiracetam

object_name: postherpetic neuralgia


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: brain aneurysm


subject: CHEBI:39548

object_name: vascular inflammations


subject: UMLS:C0016004

subject_name: Beriplast P

object_name: lymphedema


subject: UMLS:C0016004

object_name: Lymphedema, CTCAE


subject: UMLS:C0016004

object_name: vulva cancer


subject: UMLS:C0016004

object_name: vulva carcinoma


subject: CHEBI:84040

object_name: Turner syndrome


subject: CHEBI:84040

object_name: primary ovarian failure


subject: CHEBI:84040

object_name: premature menopause


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:36002


subject: CHEBI:36002


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:27881


subject: CHEBI:27881


subject: CHEBI:47458

subject_name: Saracatinib

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:47458

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:47458

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:74705

subject_name: Met-Leu

object_name: gingivitis


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:84500

subject_name: varenicline

object_name: Electronic cigarette exposure history


subject: CHEBI:567361

subject_name: Cladribine

object_name: chronic progressive multiple sclerosis


subject: CHEBI:59224

subject_name: Cetrorelix

object_name: benign prostatic hyperplasia


subject: UMLS:C2976142

subject_name: cetrorelix pamoate


subject: CHEBI:177705

subject_name: Birinapant

object_name: acute myeloid leukemia


subject: UMLS:C2981814


subject: UMLS:C4744992

subject_name: Factor B Inhibitor LNP023


subject: CHEBI:229652

subject_name: Iptacopan


subject: CHEBI:229652


subject: UMLS:C1321801

subject_name: Fiber brand of calcium polycarbophil

object_name: chronic kidney disease


subject: UMLS:C1321801

object_name: Chronic uremia


subject: UMLS:C0225326

subject_name: fiber


subject: UMLS:C0225326


subject: UMLS:C3493556

object_name: bladder disease


subject: UMLS:C3493556

object_name: urinary system disorder


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: CHEBI:28364

subject_name: Icosapent

object_name: cancer


subject: CHEBI:28364

object_name: neoplasm


subject: CHEBI:28364

object_name: Muscle Atrophy


subject: CHEBI:28364

object_name: Paresis


subject: CHEBI:28364

object_name: Muscle weakness


subject: CHEBI:28364

object_name: Weight loss


subject: CHEBI:28364

object_name: Weight Loss, CTCAE


subject: CHEBI:37144

subject_name: epichlorohydrin

object_name: Malignant cachexia


subject: CHEBI:37144


subject: CHEBI:37144


subject: CHEBI:37144


subject: CHEBI:37144


subject: CHEBI:37144


subject: CHEBI:37144


subject: CHEBI:37144


subject: PR:000016352

subject_name: metalloproteinase inhibitor 1


subject: PR:000016352


subject: PR:000016352


subject: PR:000016352


subject: PR:000016352


subject: PR:000016352


subject: PR:000016352


subject: PR:000016352


subject: CHEBI:16347

subject_name: Levocarnitine


subject: CHEBI:16347


subject: CHEBI:16347


subject: CHEBI:16347


subject: CHEBI:16347


subject: CHEBI:16347


subject: CHEBI:73582

subject_name: Leu-Cys


subject: CHEBI:73582


subject: CHEBI:73582


subject: CHEBI:73582


subject: CHEBI:73582


subject: CHEBI:73582


subject: CHEBI:73582


subject: CHEBI:73582


subject: CHEBI:37084

subject_name: beta-Hydroxyisovaleric acid


subject: CHEBI:37084


subject: CHEBI:37084


subject: CHEBI:37084


subject: CHEBI:37084


subject: CHEBI:37084


subject: CHEBI:37084


subject: CHEBI:137359


subject: CHEBI:137359


subject: CHEBI:137359


subject: CHEBI:137359


subject: CHEBI:137359


subject: CHEBI:137359


subject: CHEBI:137359


subject: CHEMBL.COMPOUND:CHEMBL4525124

subject_name: HMB


subject: CHEMBL.COMPOUND:CHEMBL4525124


subject: CHEMBL.COMPOUND:CHEMBL4525124


subject: CHEMBL.COMPOUND:CHEMBL4525124


subject: CHEMBL.COMPOUND:CHEMBL4525124


subject: CHEMBL.COMPOUND:CHEMBL4525124


subject: CHEMBL.COMPOUND:CHEMBL4525124


subject: CHEBI:3395

subject_name: carbidopa

object_name: autonomic nervous system disorder


subject: CHEBI:3395

object_name: multiple system atrophy


subject: CHEBI:94430

subject_name: DL-Carbidopa


subject: CHEBI:94430


subject: CHEBI:39585

subject_name: Carbidopa


subject: CHEBI:39585


subject: CHEBI:4798

subject_name: Entacapone


subject: CHEBI:4798


subject: CHEBI:45783

subject_name: Imatinib

object_name: SARS-CoV-2 acute respiratory disease


subject: UNII:B72HH48FLU

subject_name: Infliximab


subject: CHEBI:2682

subject_name: Amphotericin B

object_name: hematopoietic and lymphoid system neoplasm


subject: PUBCHEM.COMPOUND:147912

subject_name: Posaconazole

object_name: Invasive fungal infection


subject: CHEBI:71025

subject_name: ulipristal

object_name: c.pregnancy; fibroid, uterus tumor


subject: CHEBI:71025

object_name: Surgical procedure, unspecified


subject: CHEBI:3223

subject_name: Buspirone

object_name: traumatic encephalopathy


subject: CHEBI:8871

subject_name: Risperidone


subject: UMLS:C2981842

object_name: psoriasis


subject: CHEBI:66910

subject_name: Axitinib

object_name: cervical cancer


subject: CHEBI:66910

object_name: cervical carcinoma


subject: CHEBI:132922

object_name: colon carcinoma


subject: CHEBI:132922

object_name: colorectal cancer


subject: CHEBI:132922

object_name: colon cancer


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:49960

subject_name: Vandetanib

object_name: Advanced Clear Cell Renal Cell Carcinoma